1 Study Coverage 1.1 Recombinant Erythropoietin Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Recombinant Erythropoietin Drugs Market Size Growth Rate by Type 1.2.2 rhEPO 1.2.3 Erythropoiesis-Stimulating Agents (ESA) 1.3 Market by Application 1.3.1 Global Recombinant Erythropoietin Drugs Market Size Growth Rate by Application 1.3.2 Chronic Kidney Disease 1.3.3 Cancer Related Anemia 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Recombinant Erythropoietin Drugs Market Size, Estimates and Forecasts 2.1.1 Global Recombinant Erythropoietin Drugs Revenue 2016-2027 2.1.2 Global Recombinant Erythropoietin Drugs Sales 2016-2027 2.2 Global Recombinant Erythropoietin Drugs, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Recombinant Erythropoietin Drugs Historical Market Size by Region (2016-2021) 2.3.1 Global Recombinant Erythropoietin Drugs Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Recombinant Erythropoietin Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Recombinant Erythropoietin Drugs Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Recombinant Erythropoietin Drugs Sales Forecast by Region (2022-2027) 2.4.2 Global Recombinant Erythropoietin Drugs Revenue Forecast by Region (2022-2027) 3 Global Recombinant Erythropoietin Drugs Competitor Landscape by Players 3.1 Global Top Recombinant Erythropoietin Drugs Manufacturers by Sales 3.1.1 Global Recombinant Erythropoietin Drugs Sales by Manufacturer (2016-2021) 3.1.2 Global Recombinant Erythropoietin Drugs Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Recombinant Erythropoietin Drugs Manufacturers by Revenue 3.2.1 Key Recombinant Erythropoietin Drugs Manufacturers Covered: Ranking by Revenue 3.2.2 Global Recombinant Erythropoietin Drugs Revenue by Manufacturers (2016-2021) 3.2.3 Global Recombinant Erythropoietin Drugs Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Recombinant Erythropoietin Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Recombinant Erythropoietin Drugs Revenue in 2020 3.2.6 Global Recombinant Erythropoietin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Recombinant Erythropoietin Drugs Price by Manufacturers 3.4 Global Recombinant Erythropoietin Drugs Manufacturing Base Distribution, Product Types 3.4.1 Recombinant Erythropoietin Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Recombinant Erythropoietin Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Recombinant Erythropoietin Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Recombinant Erythropoietin Drugs Market Size by Type (2016-2021) 4.1.1 Global Recombinant Erythropoietin Drugs Sales by Type (2016-2021) 4.1.2 Global Recombinant Erythropoietin Drugs Revenue by Type (2016-2021) 4.1.3 Recombinant Erythropoietin Drugs Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Recombinant Erythropoietin Drugs Market Size Forecast by Type (2022-2027) 4.2.1 Global Recombinant Erythropoietin Drugs Sales Forecast by Type (2022-2027) 4.2.2 Global Recombinant Erythropoietin Drugs Revenue Forecast by Type (2022-2027) 4.2.3 Recombinant Erythropoietin Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Recombinant Erythropoietin Drugs Market Size by Application (2016-2021) 5.1.1 Global Recombinant Erythropoietin Drugs Sales by Application (2016-2021) 5.1.2 Global Recombinant Erythropoietin Drugs Revenue by Application (2016-2021) 5.1.3 Recombinant Erythropoietin Drugs Price by Application (2016-2021) 5.2 Recombinant Erythropoietin Drugs Market Size Forecast by Application (2022-2027) 5.2.1 Global Recombinant Erythropoietin Drugs Sales Forecast by Application (2022-2027) 5.2.2 Global Recombinant Erythropoietin Drugs Revenue Forecast by Application (2022-2027) 5.2.3 Global Recombinant Erythropoietin Drugs Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Recombinant Erythropoietin Drugs Market Size YoY Growth 2016-2027 6.1.1 Japan Recombinant Erythropoietin Drugs Sales YoY Growth 2016-2027 6.1.2 Japan Recombinant Erythropoietin Drugs Revenue YoY Growth 2016-2027 6.1.3 Japan Recombinant Erythropoietin Drugs Market Share in Global Market 2016-2027 6.2 Japan Recombinant Erythropoietin Drugs Market Size by Players (International and Local Players) 6.2.1 Japan Top Recombinant Erythropoietin Drugs Players by Sales (2016-2021) 6.2.2 Japan Top Recombinant Erythropoietin Drugs Players by Revenue (2016-2021) 6.3 Japan Recombinant Erythropoietin Drugs Historic Market Review by Type (2016-2021) 6.3.1 Japan Recombinant Erythropoietin Drugs Sales Market Share by Type (2016-2021) 6.3.2 Japan Recombinant Erythropoietin Drugs Revenue Market Share by Type (2016-2021) 6.3.3 Japan Recombinant Erythropoietin Drugs Price by Type (2016-2021) 6.4 Japan Recombinant Erythropoietin Drugs Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Recombinant Erythropoietin Drugs Sales Forecast by Type (2022-2027) 6.4.2 Japan Recombinant Erythropoietin Drugs Revenue Forecast by Type (2022-2027) 6.4.3 Japan Recombinant Erythropoietin Drugs Price Forecast by Type (2022-2027) 6.5 Japan Recombinant Erythropoietin Drugs Historic Market Review by Application (2016-2021) 6.5.1 Japan Recombinant Erythropoietin Drugs Sales Market Share by Application (2016-2021) 6.5.2 Japan Recombinant Erythropoietin Drugs Revenue Market Share by Application (2016-2021) 6.5.3 Japan Recombinant Erythropoietin Drugs Price by Application (2016-2021) 6.6 Japan Recombinant Erythropoietin Drugs Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Recombinant Erythropoietin Drugs Sales Forecast by Application (2022-2027) 6.6.2 Japan Recombinant Erythropoietin Drugs Revenue Forecast by Application (2022-2027) 6.6.3 Japan Recombinant Erythropoietin Drugs Price Forecast by Application (2022-2027) 7 North America 7.1 North America Recombinant Erythropoietin Drugs Market Size YoY Growth 2016-2027 7.2 North America Recombinant Erythropoietin Drugs Market Facts & Figures by Country 7.2.1 North America Recombinant Erythropoietin Drugs Sales by Country (2016-2021) 7.2.2 North America Recombinant Erythropoietin Drugs Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Recombinant Erythropoietin Drugs Market Size YoY Growth 2016-2027 8.2 Asia Pacific Recombinant Erythropoietin Drugs Market Facts & Figures by Region 8.2.1 Asia Pacific Recombinant Erythropoietin Drugs Sales by Region (2016-2021) 8.2.2 Asia Pacific Recombinant Erythropoietin Drugs Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Recombinant Erythropoietin Drugs Market Size YoY Growth 2016-2027 9.2 Europe Recombinant Erythropoietin Drugs Market Facts & Figures by Country 9.2.1 Europe Recombinant Erythropoietin Drugs Sales by Country (2016-2021) 9.2.2 Europe Recombinant Erythropoietin Drugs Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Recombinant Erythropoietin Drugs Market Size YoY Growth 2016-2027 10.2 Latin America Recombinant Erythropoietin Drugs Market Facts & Figures by Country 10.2.1 Latin America Recombinant Erythropoietin Drugs Sales by Country (2016-2021) 10.2.2 Latin America Recombinant Erythropoietin Drugs Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Recombinant Erythropoietin Drugs Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Recombinant Erythropoietin Drugs Market Facts & Figures by Country 11.2.1 Middle East and Africa Recombinant Erythropoietin Drugs Sales by Country (2016-2021) 11.2.2 Middle East and Africa Recombinant Erythropoietin Drugs Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Amgen 12.1.1 Amgen Corporation Information 12.1.2 Amgen Description and Business Overview 12.1.3 Amgen Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Amgen Recombinant Erythropoietin Drugs Products Offered 12.1.5 Amgen Recent Development 12.2 Johnson & Johnson 12.2.1 Johnson & Johnson Corporation Information 12.2.2 Johnson & Johnson Description and Business Overview 12.2.3 Johnson & Johnson Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Johnson & Johnson Recombinant Erythropoietin Drugs Products Offered 12.2.5 Johnson & Johnson Recent Development 12.3 Kyowa Hakko Kirin 12.3.1 Kyowa Hakko Kirin Corporation Information 12.3.2 Kyowa Hakko Kirin Description and Business Overview 12.3.3 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Products Offered 12.3.5 Kyowa Hakko Kirin Recent Development 12.4 Roche 12.4.1 Roche Corporation Information 12.4.2 Roche Description and Business Overview 12.4.3 Roche Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Roche Recombinant Erythropoietin Drugs Products Offered 12.4.5 Roche Recent Development 12.5 3SBio Group 12.5.1 3SBio Group Corporation Information 12.5.2 3SBio Group Description and Business Overview 12.5.3 3SBio Group Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 12.5.4 3SBio Group Recombinant Erythropoietin Drugs Products Offered 12.5.5 3SBio Group Recent Development 12.6 Celltrion, Inc 12.6.1 Celltrion, Inc Corporation Information 12.6.2 Celltrion, Inc Description and Business Overview 12.6.3 Celltrion, Inc Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Celltrion, Inc Recombinant Erythropoietin Drugs Products Offered 12.6.5 Celltrion, Inc Recent Development 12.7 Teva Pharmaceutical Industries Ltd 12.7.1 Teva Pharmaceutical Industries Ltd Corporation Information 12.7.2 Teva Pharmaceutical Industries Ltd Description and Business Overview 12.7.3 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Products Offered 12.7.5 Teva Pharmaceutical Industries Ltd Recent Development 12.8 F. Hoffmann-La Roche Ltd 12.8.1 F. Hoffmann-La Roche Ltd Corporation Information 12.8.2 F. Hoffmann-La Roche Ltd Description and Business Overview 12.8.3 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 12.8.4 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Products Offered 12.8.5 F. Hoffmann-La Roche Ltd Recent Development 12.9 LG Life Sciences Ltd 12.9.1 LG Life Sciences Ltd Corporation Information 12.9.2 LG Life Sciences Ltd Description and Business Overview 12.9.3 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 12.9.4 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Products Offered 12.9.5 LG Life Sciences Ltd Recent Development 12.10 Biocon Limited 12.10.1 Biocon Limited Corporation Information 12.10.2 Biocon Limited Description and Business Overview 12.10.3 Biocon Limited Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Biocon Limited Recombinant Erythropoietin Drugs Products Offered 12.10.5 Biocon Limited Recent Development 12.11 Amgen 12.11.1 Amgen Corporation Information 12.11.2 Amgen Description and Business Overview 12.11.3 Amgen Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Amgen Recombinant Erythropoietin Drugs Products Offered 12.11.5 Amgen Recent Development 12.12 Sun Pharmaceutical Industries Ltd 12.12.1 Sun Pharmaceutical Industries Ltd Corporation Information 12.12.2 Sun Pharmaceutical Industries Ltd Description and Business Overview 12.12.3 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Sun Pharmaceutical Industries Ltd Products Offered 12.12.5 Sun Pharmaceutical Industries Ltd Recent Development 12.13 Dr. Reddy's Laboratories Ltd 12.13.1 Dr. Reddy's Laboratories Ltd Corporation Information 12.13.2 Dr. Reddy's Laboratories Ltd Description and Business Overview 12.13.3 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Dr. Reddy's Laboratories Ltd Products Offered 12.13.5 Dr. Reddy's Laboratories Ltd Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Recombinant Erythropoietin Drugs Industry Trends 13.2 Recombinant Erythropoietin Drugs Market Drivers 13.3 Recombinant Erythropoietin Drugs Market Challenges 13.4 Recombinant Erythropoietin Drugs Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Recombinant Erythropoietin Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Recombinant Erythropoietin Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of rhEPO Table 3. Major Manufacturers of Erythropoiesis-Stimulating Agents (ESA) Table 4. Global Recombinant Erythropoietin Drugs Market Size Growth Rate by Application (2021-2027) & (KG) Table 5. Global Recombinant Erythropoietin Drugs Market Size by Region (KG) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global Recombinant Erythropoietin Drugs Sales by Regions (2016-2021) & (KG) Table 7. Global Recombinant Erythropoietin Drugs Sales Market Share by Regions (2016-2021) Table 8. Global Recombinant Erythropoietin Drugs Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global Recombinant Erythropoietin Drugs Sales Forecast by Region (2022-2027) & (KG) Table 10. Global Recombinant Erythropoietin Drugs Sales Market Share Forecast by Region (2022-2027) Table 11. Global Recombinant Erythropoietin Drugs Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global Recombinant Erythropoietin Drugs Revenue Market Share Forecast by Region (2022-2027) Table 13. Global Recombinant Erythropoietin Drugs Sales by Manufacturers (2016-2021) (KG) Table 14. Global Recombinant Erythropoietin Drugs Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top Recombinant Erythropoietin Drugs Manufacturers by Revenue (US$ Million) in 2020 Table 16. Recombinant Erythropoietin Drugs Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. Recombinant Erythropoietin Drugs Revenue Share by Manufacturers (2016-2021) Table 18. Global Recombinant Erythropoietin Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global Recombinant Erythropoietin Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Erythropoietin Drugs as of 2020) Table 20. Key Manufacturers Recombinant Erythropoietin Drugs Price (2016-2021) (USD/g) Table 21. Recombinant Erythropoietin Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Recombinant Erythropoietin Drugs Product Type Table 23. Date of International Manufacturers Enter into Recombinant Erythropoietin Drugs Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Recombinant Erythropoietin Drugs Sales by Type (2016-2021) (KG) Table 26. Global Recombinant Erythropoietin Drugs Sales Share by Type (2016-2021) Table 27. Global Recombinant Erythropoietin Drugs Revenue by Type (2016-2021) (US$ Million) Table 28. Global Recombinant Erythropoietin Drugs Revenue Share by Type (2016-2021) Table 29. Recombinant Erythropoietin Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/g) Table 30. Global Recombinant Erythropoietin Drugs Sales Forecast by Type (2022-2027) & (KG) Table 31. Global Recombinant Erythropoietin Drugs Sales Market Share Forecast by Type (2022-2027) Table 32. Global Recombinant Erythropoietin Drugs Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global Recombinant Erythropoietin Drugs Revenue Market Share Forecast by Type (2022-2027) Table 34. Global Recombinant Erythropoietin Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/g) Table 35. Global Recombinant Erythropoietin Drugs Sales by Application (2016-2021) (KG) Table 36. Global Recombinant Erythropoietin Drugs Sales Share by Application (2016-2021) Table 37. Global Recombinant Erythropoietin Drugs Revenue by Application (2016-2021) (US$ Million) Table 38. Global Recombinant Erythropoietin Drugs Revenue Share by Application (2016-2021) Table 39. Recombinant Erythropoietin Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/g) Table 40. Global Recombinant Erythropoietin Drugs Sales Forecast by Application (2022-2027) & (KG) Table 41. Global Recombinant Erythropoietin Drugs Sales Market Share Forecast by Application (2022-2027) Table 42. Global Recombinant Erythropoietin Drugs Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global Recombinant Erythropoietin Drugs Revenue Market Share Forecast by Application (2022-2027) Table 44. Global Recombinant Erythropoietin Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/g) Table 45. Japan Recombinant Erythropoietin Drugs Sales (KG) of Key Companies (2016-2021) Table 46. Japan Recombinant Erythropoietin Drugs Sales Share by Company (2016-2021) Table 47. Japan Recombinant Erythropoietin Drugs Revenue (US$ Million) by Company (2016-2021) Table 48. Japan Recombinant Erythropoietin Drugs Revenue Share by Company (2016-2021) Table 49. Japan Recombinant Erythropoietin Drugs Sales (KG) by Type (2016-2021) Table 50. Japan Recombinant Erythropoietin Drugs Sales Share by Type (2016-2021) Table 51. Japan Recombinant Erythropoietin Drugs Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. Japan Recombinant Erythropoietin Drugs Price (USD/g) by Type (2016-2021) Table 53. Japan Recombinant Erythropoietin Drugs Sales (KG) by Type (2022-2027) Table 54. Japan Recombinant Erythropoietin Drugs Sales Share by Type (2022-2027) Table 55. Japan Recombinant Erythropoietin Drugs Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. Japan Recombinant Erythropoietin Drugs Revenue Share by Type (2022-2027) Table 57. Japan Recombinant Erythropoietin Drugs Price (USD/g) by Type (2022-2027) Table 58. Japan Recombinant Erythropoietin Drugs Sales (KG) by Application (2016-2021) Table 59. Japan Recombinant Erythropoietin Drugs Sales Share by Application (2016-2021) Table 60. Japan Recombinant Erythropoietin Drugs Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. Japan Recombinant Erythropoietin Drugs Price (USD/g) by Application (2016-2021) Table 62. Japan Recombinant Erythropoietin Drugs Sales (KG) by Application (2022-2027) Table 63. Japan Recombinant Erythropoietin Drugs Sales Share by Application (2022-2027) Table 64. Japan Recombinant Erythropoietin Drugs Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. Japan Recombinant Erythropoietin Drugs Revenue Share by Application (2022-2027) Table 66. Japan Recombinant Erythropoietin Drugs Price (USD/g) by Application (2022-2027) Table 67. North America Recombinant Erythropoietin Drugs Sales by Country (2016-2021) & (KG) Table 68. North America Recombinant Erythropoietin Drugs Sales Market Share by Country (2016-2021) Table 69. North America Recombinant Erythropoietin Drugs Revenue by Country (2016-2021) & (US$ Million) Table 70. North America Recombinant Erythropoietin Drugs Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific Recombinant Erythropoietin Drugs Sales by Region (2016-2021) & (KG) Table 72. Asia Pacific Recombinant Erythropoietin Drugs Sales Market Share by Region (2016-2021) Table 73. Asia Pacific Recombinant Erythropoietin Drugs Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific Recombinant Erythropoietin Drugs Revenue Market Share by Region (2016-2021) Table 75. Europe Recombinant Erythropoietin Drugs Sales by Country (2016-2021) & (KG) Table 76. Europe Recombinant Erythropoietin Drugs Sales Market Share by Country (2016-2021) Table 77. Europe Recombinant Erythropoietin Drugs Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe Recombinant Erythropoietin Drugs Revenue Market Share by Country (2016-2021) Table 79. Latin America Recombinant Erythropoietin Drugs Sales by Country (2016-2021) & (KG) Table 80. Latin America Recombinant Erythropoietin Drugs Sales Market Share by Country (2016-2021) Table 81. Latin Americaa Recombinant Erythropoietin Drugs Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America Recombinant Erythropoietin Drugs Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa Recombinant Erythropoietin Drugs Sales by Country (2016-2021) & (KG) Table 84. Middle East and Africa Recombinant Erythropoietin Drugs Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa Recombinant Erythropoietin Drugs Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa Recombinant Erythropoietin Drugs Revenue Market Share by Country (2016-2021) Table 87. Amgen Corporation Information Table 88. Amgen Description and Business Overview Table 89. Amgen Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 90. Amgen Recombinant Erythropoietin Drugs Product Table 91. Amgen Recent Development Table 92. Johnson & Johnson Corporation Information Table 93. Johnson & Johnson Description and Business Overview Table 94. Johnson & Johnson Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 95. Johnson & Johnson Product Table 96. Johnson & Johnson Recent Development Table 97. Kyowa Hakko Kirin Corporation Information Table 98. Kyowa Hakko Kirin Description and Business Overview Table 99. Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 100. Kyowa Hakko Kirin Product Table 101. Kyowa Hakko Kirin Recent Development Table 102. Roche Corporation Information Table 103. Roche Description and Business Overview Table 104. Roche Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 105. Roche Product Table 106. Roche Recent Development Table 107. 3SBio Group Corporation Information Table 108. 3SBio Group Description and Business Overview Table 109. 3SBio Group Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 110. 3SBio Group Product Table 111. 3SBio Group Recent Development Table 112. Celltrion, Inc Corporation Information Table 113. Celltrion, Inc Description and Business Overview Table 114. Celltrion, Inc Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 115. Celltrion, Inc Product Table 116. Celltrion, Inc Recent Development Table 117. Teva Pharmaceutical Industries Ltd Corporation Information Table 118. Teva Pharmaceutical Industries Ltd Description and Business Overview Table 119. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 120. Teva Pharmaceutical Industries Ltd Product Table 121. Teva Pharmaceutical Industries Ltd Recent Development Table 122. F. Hoffmann-La Roche Ltd Corporation Information Table 123. F. Hoffmann-La Roche Ltd Description and Business Overview Table 124. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 125. F. Hoffmann-La Roche Ltd Product Table 126. F. Hoffmann-La Roche Ltd Recent Development Table 127. LG Life Sciences Ltd Corporation Information Table 128. LG Life Sciences Ltd Description and Business Overview Table 129. LG Life Sciences Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 130. LG Life Sciences Ltd Product Table 131. LG Life Sciences Ltd Recent Development Table 132. Biocon Limited Corporation Information Table 133. Biocon Limited Description and Business Overview Table 134. Biocon Limited Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 135. Biocon Limited Product Table 136. Biocon Limited Recent Development Table 137. Intas Pharmaceuticals Ltd Corporation Information Table 138. Intas Pharmaceuticals Ltd Description and Business Overview Table 139. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 140. Intas Pharmaceuticals Ltd Product Table 141. Intas Pharmaceuticals Ltd Recent Development Table 142. Sun Pharmaceutical Industries Ltd Corporation Information Table 143. Sun Pharmaceutical Industries Ltd Description and Business Overview Table 144. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 145. Sun Pharmaceutical Industries Ltd Product Table 146. Sun Pharmaceutical Industries Ltd Recent Development Table 147. Dr. Reddy's Laboratories Ltd Corporation Information Table 148. Dr. Reddy's Laboratories Ltd Description and Business Overview Table 149. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 150. Dr. Reddy's Laboratories Ltd Product Table 151. Dr. Reddy's Laboratories Ltd Recent Development Table 152. Recombinant Erythropoietin Drugs Market Trends Table 153. Recombinant Erythropoietin Drugs Market Drivers Table 154. Recombinant Erythropoietin Drugs Market Challenges Table 155. Recombinant Erythropoietin Drugs Market Restraints Table 156. Recombinant Erythropoietin Drugs Customers List Table 157. Recombinant Erythropoietin Drugs Distributors List Table 158. Research Programs/Design for This Report Table 159. Key Data Information from Secondary Sources Table 160. Key Data Information from Primary Sources List of Figures Figure 1. Recombinant Erythropoietin Drugs Product Picture Figure 2. Global Recombinant Erythropoietin Drugs Sales Market Share by Type in 2020 & 2027 Figure 3. rhEPO Product Picture Figure 4. Erythropoiesis-Stimulating Agents (ESA) Product Picture Figure 5. Global Recombinant Erythropoietin Drugs Sales Market Share by Application in 2020 & 2027 Figure 6. Chronic Kidney Disease Figure 7. Cancer Related Anemia Figure 8. Others Figure 9. Recombinant Erythropoietin Drugs Report Years Considered Figure 10. Global Recombinant Erythropoietin Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Recombinant Erythropoietin Drugs Market Size 2016-2027 (US$ Million) Figure 12. Global Recombinant Erythropoietin Drugs Sales 2016-2027 (KG) Figure 13. Global Recombinant Erythropoietin Drugs Market Size Market Share by Region: 2021 Versus 2027 Figure 14. Global Recombinant Erythropoietin Drugs Sales Market Share by Region (2016-2021) Figure 15. Global Recombinant Erythropoietin Drugs Sales Market Share by Region in 2020 Figure 16. Global Recombinant Erythropoietin Drugs Revenue Market Share by Region (2016-2021) Figure 17. Global Recombinant Erythropoietin Drugs Revenue Market Share by Region in 2020 Figure 18. Global Recombinant Erythropoietin Drugs Sales Share by Manufacturer in 2020 Figure 19. The Top 10 and 5 Players Market Share by Recombinant Erythropoietin Drugs Revenue in 2020 Figure 20. Recombinant Erythropoietin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global Recombinant Erythropoietin Drugs Sales Market Share by Type (2016-2021) Figure 22. Global Recombinant Erythropoietin Drugs Sales Market Share by Type in 2020 Figure 23. Global Recombinant Erythropoietin Drugs Revenue Market Share by Type (2016-2021) Figure 24. Global Recombinant Erythropoietin Drugs Revenue Market Share by Type in 2020 Figure 25. Global Recombinant Erythropoietin Drugs Sales Market Share by Application (2016-2021) Figure 26. Global Recombinant Erythropoietin Drugs Sales Market Share by Application in 2020 Figure 27. Global Recombinant Erythropoietin Drugs Revenue Market Share by Application (2016-2021) Figure 28. Global Recombinant Erythropoietin Drugs Revenue Market Share by Application in 2020 Figure 29. Japan Recombinant Erythropoietin Drugs Sales Growth Rate 2016-2027 (KG) Figure 30. Japan Recombinant Erythropoietin Drugs Revenue Growth Rate 2016-2027 (US$ Million) Figure 31. Japan Recombinant Erythropoietin Drugs Market Share in Global Market 2016-2027 Figure 32. Japan 5 and 10 Largest Recombinant Erythropoietin Drugs Players Market Share by Revenue in Recombinant Erythropoietin Drugs in 2020 Figure 33. Japan Recombinant Erythropoietin Drugs Revenue Share by Type (2016-2021) Figure 34. Japan Recombinant Erythropoietin Drugs Revenue Growth Rate by Type in 2016 & 2020 Figure 35. Japan Recombinant Erythropoietin Drugs Revenue Share by Application (2016-2021) Figure 36. Japan Recombinant Erythropoietin Drugs Revenue Growth Rate by Application in 2016 & 2020 Figure 37. North America Recombinant Erythropoietin Drugs Sales Growth Rate 2016-2021 (KG) Figure 38. North America Recombinant Erythropoietin Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 39. North America Recombinant Erythropoietin Drugs Sales Market Share by Country in 2020 Figure 40. North America Recombinant Erythropoietin Drugs Revenue Market Share by Country in 2020 Figure 41. U.S. Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 42. U.S. Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Canada Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 44. Canada Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Europe Recombinant Erythropoietin Drugs Sales Growth Rate 2016-2021 (KG) Figure 46. Europe Recombinant Erythropoietin Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 47. Europe Recombinant Erythropoietin Drugs Sales Market Share by Country in 2020 Figure 48. Europe Recombinant Erythropoietin Drugs Revenue Market Share by Country in 2020 Figure 49. Germany Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 50. Germany Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. France Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 52. France Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. U.K. Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 54. U.K. Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. Italy Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 56. Italy Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Russia Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 58. Russia Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Asia Pacific Recombinant Erythropoietin Drugs Sales Growth Rate 2016-2021 (KG) Figure 60. Asia Pacific Recombinant Erythropoietin Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 61. Asia Pacific Recombinant Erythropoietin Drugs Sales Market Share by Region in 2020 Figure 62. Asia Pacific Recombinant Erythropoietin Drugs Revenue Market Share by Region in 2020 Figure 63. China Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 64. China Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 65. Japan Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 66. Japan Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. South Korea Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 68. South Korea Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. India Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 70. India Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. Australia Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 72. Australia Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Taiwan Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 74. Taiwan Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Indonesia Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 76. Indonesia Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Thailand Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 78. Thailand Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Malaysia Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 80. Malaysia Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Philippines Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 82. Philippines Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Vietnam Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 84. Vietnam Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Latin America Recombinant Erythropoietin Drugs Sales Growth Rate 2016-2021 (KG) Figure 86. Latin America Recombinant Erythropoietin Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 87. Latin America Recombinant Erythropoietin Drugs Sales Market Share by Country in 2020 Figure 88. Latin America Recombinant Erythropoietin Drugs Revenue Market Share by Country in 2020 Figure 89. Mexico Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 90. Mexico Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 91. Brazil Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 92. Brazil Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Argentina Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 94. Argentina Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Middle East and Africa Recombinant Erythropoietin Drugs Sales Growth Rate 2016-2021 (KG) Figure 96. Middle East and Africa Recombinant Erythropoietin Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 97. Middle East and Africa Recombinant Erythropoietin Drugs Sales Market Share by Country in 2020 Figure 98. Middle East and Africa Recombinant Erythropoietin Drugs Revenue Market Share by Country in 2020 Figure 99. Turkey Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 100. Turkey Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 101. Saudi Arabia Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 102. Saudi Arabia Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. U.A.E Recombinant Erythropoietin Drugs Sales Growth Rate (2016-2021) (KG) Figure 104. U.A.E Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. Recombinant Erythropoietin Drugs Value Chain Figure 106. Channels of Distribution Figure 107. Distributors Profiles Figure 108. Bottom-up and Top-down Approaches for This Report Figure 109. Data Triangulation Figure 110. Key Executives Interviewed

Amgen Johnson & Johnson Kyowa Hakko Kirin Roche 3SBio Group Celltrion, Inc Teva Pharmaceutical Industries Ltd F. Hoffmann-La Roche Ltd LG Life Sciences Ltd Biocon Limited Intas Pharmaceuticals Ltd Sun Pharmaceutical Industries Ltd Dr. Reddy's Laboratories Ltd